United States
Germany
Japan
United Kingdom
China
Lyve1 (NM_053247) Mouse Tagged ORF Clone Lentiviral Particle
CAT＃: MR204596L1V
- LentiORF®
-
Lenti ORF particles, Lyve1 (Myc-DDK-tagged) - Mouse lymphatic vessel endothelial hyaluronan receptor 1 (Lyve1), 200ul, >10^7 TU/mL
Need custom lentivirus service?
Get a free quote
CNY 7,410.00
货期*
详询
规格
Product images
经常一起买 (3)
Specifications
| Product Data | |
| Product Name | Lyve1 (NM_053247) Mouse Tagged ORF Clone Lentiviral Particle |
| Synonyms | 1200012G08Rik; Crsbp-1; Lyve-1; Xlkd1 |
| Vector | pLenti-C-Myc-DDK |
| ACCN | NM_053247 |
| ORF Size | 957 bp |
| Sequence Data |
The ORF insert of this clone is exactly the same as(MR204596).
|
| OTI Disclaimer | The molecular sequence of this clone aligns with the gene accession number as a point of reference only. However, individual transcript sequences of the same gene can differ through naturally occurring variations (e.g. polymorphisms), each with its own valid existence. This clone is substantially in agreement with the reference, but a complete review of all prevailing variants is recommended prior to use. More info |
| OTI Annotation | This clone was engineered to express the complete ORF with an expression tag. Expression varies depending on the nature of the gene. |
| Reference Data | |
| RefSeq | NM_053247.4, NP_444477.2 |
| RefSeq Size | 2607 bp |
| RefSeq ORF | 957 bp |
| Locus ID | 114332 |
| Gene Summary | Ligand-specific transporter trafficking between intracellular organelles (TGN) and the plasma membrane. Plays a role in autocrine regulation of cell growth mediated by growth regulators containing cell surface retention sequence binding (CRS). May act as a hyaluronan (HA) transporter, either mediating its uptake for catabolism within lymphatic endothelial cells themselves, or its transport into the lumen of afferent lymphatic vessels for subsequent re-uptake and degradation in lymph nodes.[UniProtKB/Swiss-Prot Function] |
Documents
| Product Manuals |
| FAQs |
| SDS |
Resources
You may also need
Customer
Reviews
Loading...
